Annual Accounts Receivable
$33.62 M
+$3.03 M+9.89%
December 31, 2024
Summary
- As of March 12, 2025, ABCL annual accounts receivable is $33.62 million, with the most recent change of +$3.03 million (+9.89%) on December 31, 2024.
- During the last 3 years, ABCL annual accounts receivable has fallen by -$126.96 million (-79.07%).
- ABCL annual accounts receivable is now -84.24% below its all-time high of $213.24 million, reached on December 31, 2020.
Performance
ABCL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$33.62 M
+$2.24 M+7.15%
December 31, 2024
Summary
- As of March 12, 2025, ABCL quarterly accounts receivable is $33.62 million, with the most recent change of +$2.24 million (+7.15%) on December 31, 2024.
- Over the past year, ABCL quarterly accounts receivable has increased by +$2.24 million (+7.15%).
- ABCL quarterly accounts receivable is now -89.95% below its all-time high of $334.40 million, reached on March 31, 2022.
Performance
ABCL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ABCL Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.9% | +7.2% |
| 3 y3 years | -79.1% | +7.2% |
| 5 y5 years | +1482.7% | +7.2% |
ABCL Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.1% | +9.9% | -90.0% | +68.0% |
| 5 y | 5-year | -84.2% | +1482.7% | -90.0% | +1482.7% |
| alltime | all time | -84.2% | +5544.1% | -90.0% | +1482.7% |
AbCellera Biologics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $33.62 M(+9.9%) | $33.62 M(+7.1%) |
| Sep 2024 | - | $31.37 M(-13.2%) |
| Jun 2024 | - | $36.14 M(+5.0%) |
| Mar 2024 | - | $34.42 M(+12.5%) |
| Dec 2023 | $30.59 M(-20.7%) | $30.59 M(-18.3%) |
| Sep 2023 | - | $37.45 M(-18.0%) |
| Jun 2023 | - | $45.68 M(+128.4%) |
| Mar 2023 | - | $20.00 M(-48.2%) |
| Dec 2022 | $38.59 M | $38.59 M(-63.6%) |
| Sep 2022 | - | $105.96 M(+100.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $52.80 M(-84.2%) |
| Mar 2022 | - | $334.40 M(+108.3%) |
| Dec 2021 | $160.58 M(-24.7%) | $160.58 M(+268.0%) |
| Sep 2021 | - | $43.63 M(+1458.9%) |
| Jun 2021 | - | $2.80 M(-88.0%) |
| Mar 2021 | - | $23.37 M(-89.0%) |
| Dec 2020 | $213.24 M(>+9900.0%) | $213.24 M(+3755.2%) |
| Sep 2020 | - | $5.53 M(+160.4%) |
| Dec 2019 | $2.12 M(+256.6%) | $2.12 M |
| Dec 2018 | $595.60 K | - |
FAQ
- What is AbCellera Biologics annual accounts receivable?
- What is the all time high annual accounts receivable for AbCellera Biologics?
- What is AbCellera Biologics annual accounts receivable year-on-year change?
- What is AbCellera Biologics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for AbCellera Biologics?
- What is AbCellera Biologics quarterly accounts receivable year-on-year change?
What is AbCellera Biologics annual accounts receivable?
The current annual accounts receivable of ABCL is $33.62 M
What is the all time high annual accounts receivable for AbCellera Biologics?
AbCellera Biologics all-time high annual accounts receivable is $213.24 M
What is AbCellera Biologics annual accounts receivable year-on-year change?
Over the past year, ABCL annual accounts receivable has changed by +$3.03 M (+9.89%)
What is AbCellera Biologics quarterly accounts receivable?
The current quarterly accounts receivable of ABCL is $33.62 M
What is the all time high quarterly accounts receivable for AbCellera Biologics?
AbCellera Biologics all-time high quarterly accounts receivable is $334.40 M
What is AbCellera Biologics quarterly accounts receivable year-on-year change?
Over the past year, ABCL quarterly accounts receivable has changed by +$2.24 M (+7.15%)